- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.08. | Amgen, AstraZeneca's Tezspire lands phase 3 eosinophilic esophagitis win, turning up heat on Dupixent | ||
| 27.08. | Artis BioSolutions expands synthetic DNA, mRNA production with Spanish facility | ||
| 27.08. | Trump set to reveal MFN pricing deals with mid-sized companies: report | ||
| 26.08. | FDA greenlights Revolution Medicines' pancreatic cancer gamechanger | ||
| 26.08. | Akeso CEO looks beyond lung cancer with biliary tract win, counters ivonescimab debate | ||
| 26.08. | Baxter issues recall of 2 products after particulate concerns resurface | ||
| 26.08. | With Trump's nominee pick in, FDA weighs new deputy commissioner posts: report | ||
| 25.08. | NAD reaches split decision on hair ad row between Kenvue and Hims & Hers | ||
| 25.08. | McKesson strikes $2.25B deal to snap up Precision Medicine Group | ||
| 25.08. | Bausch + Lomb flops in ph. 2 with Xiidra and Miebo but advances combo to ph. 3 | ||
| 25.08. | Johnson & Johnson scores 1st FDA label expansion for Imaavy | ||
| 24.08. | Merck, AstraZeneca lawsuits against Medicare price negotiations swatted down | ||
| 24.08. | Hansa lays groundwork for Nasdaq debut ahead of US kidney transplant drug verdict | ||
| 24.08. | After Trump order, RFK Jr. seeks input on US pediatric vaccine recommendations | ||
| 24.08. | Cellares CEO seeks to 'resize' company after loss of 'large' cell therapy manufacturing customer | ||
| 24.08. | Daiichi Sankyo promotes Ken Keller to lead new commercialization unit | ||
| 21.08. | Lundbeck continues neuroscience evolution as CEO keeps company 'punching above its weight' | ||
| 21.08. | The Oral GLP-1 Tracker: Novo's Wegovy pill back on track as Lilly's momentum slows | ||
| 20.08. | Roche earmarks $750M to double the size of its Oregon manufacturing facility | ||
| 20.08. | Xspray's Dasynoc approval bid foiled again by FDA's manufacturer concerns | ||
| 20.08. | Aurinia settles with Teva, helping stave off potential Lupkynis generic until late 2036 | ||
| 20.08. | B. Braun recalls IV solution from US, Canada hospitals on particle contamination concerns | ||
| 20.08. | Lucid Group names leading Publicis Health exec as new CEO | ||
| 20.08. | Boehringer Ingelheim again rises up rare disease reputation rankings | ||
| 19.08. | SK strikes settlement with MSN over future Xcopri generic: reports |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.